Advisory Commission on Childhood Vaccines; Notice of Meeting, 14311 [2013-04953]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 43 / Tuesday, March 5, 2013 / Notices
1. McEntire, Jennifer and Bhatt, Tejas, ‘‘Pilot
Projects for Improving Product Tracing
Along the Food Supply System—Final
Report,’’ Institute of Food Technologists,
August 2012.
Dated: February 27, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013–04997 Filed 3–4–13; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
emcdonald on DSK67QTVN1PROD with NOTICES
Advisory Commission on Childhood
Vaccines; Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Advisory Commission on
Childhood Vaccines (ACCV).
Date and Time: March 07, 2013, 10:00
a.m. to 4:00 p.m. EDT.
Place: Audio Conference Call.
The ACCV will meet on Thursday,
March 7, from 10:00 a.m. to 4:00 p.m.
(EDT). The public can join the meeting
via audio conference call by dialing 1–
800–369–3104 on March 7 and
providing the following information:
Leader’s Name: Dr. Vito Caserta.
Password: ACCV.
Agenda: The agenda items for the
March meeting will include, but are not
limited to: Updates from the Division of
Vaccine Injury Compensation (DVIC),
Department of Justice (DOJ), National
Vaccine Program Office (NVPO),
Immunization Safety Office (Centers for
Disease Control and Prevention),
National Institute of Allergy and
Infectious Diseases (National Institutes
of Health) and Center for Biologics,
Evaluation and Research (Food and
Drug Administration). A draft agenda
and additional meeting materials will be
posted on the ACCV Web site (https://
www.hrsa.gov/vaccinecompensation/
accv.htm) prior to the meeting. Agenda
items are subject to change as priorities
dictate.
Public Comment: Persons interested
in providing an oral presentation should
submit a written request, along with a
copy of their presentation to: Annie
Herzog, DVIC, Healthcare Systems
Bureau (HSB), Health Resources and
Services Administration (HRSA), Room
11C–26, 5600 Fishers Lane, Rockville,
MD 20857 or email: aherzog@hrsa.gov.
Requests should contain the name,
address, telephone number, email
address, and any business or
VerDate Mar<15>2010
15:14 Mar 04, 2013
Jkt 229001
professional affiliation of the person
desiring to make an oral presentation.
Groups having similar interests are
requested to combine their comments
and present them through a single
representative. The allocation of time
may be adjusted to accommodate the
level of expressed interest. DVIC will
notify each presenter by email, mail or
telephone of their assigned presentation
time. Persons who do not file an
advance request for a presentation, but
desire to make an oral statement, may
announce it at the time of the public
comment period. Public participation
and ability to comment will be limited
to space and time as it permits.
For Further Information Contact:
Anyone requiring information regarding
the ACCV should contact Annie Herzog,
DVIC, HSB, HRSA, Room 11C–26, 5600
Fishers Lane, Rockville, MD 20857;
telephone (301) 443–6593 or email:
aherzog@hrsa.gov.
Dated: February 26, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2013–04953 Filed 3–4–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Statement of Organization, Functions
and Delegations of Authority
This notice amends Part R of the
Statement of Organization, Functions
and Delegations of Authority of the
Department of Health and Human
Services (HHS), Health Resources and
Services Administration (HRSA) (60 FR
56605, as amended November 6, 1995;
as last amended at 78 FR 956–957, dated
January 7, 2013).
This notice reflects organizational
changes to the Health Resources and
Services Administration. This notice
updates the functional statement for the
Office of Federal Assistance
Management (RJ). Specifically, this
notice: (1) Moves the grant officer and
loan officer function from the Office of
the Associate Administrator (RJ) to the
Division of Grants Management
Operations (RJ3); and (2) moves the
electronic grant management system
function from the Division of Grants
Management Operations (RJ3) to the
Office of the Associate Administrator
(RJ).
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
14311
Chapter RJ—Office of Federal
Assistance Management
Section RJ–20, Functions
(1) Delete the functional statement for
the Office of the Associate
Administrator (RJ) and the functional
statement for the Division of Grants
Management Operations (RJ3), and
replace in their entirety.
Office of Federal Assistance
Management (RJ)
Provides national leadership in the
administration and assurance of the
financial integrity of HRSA’s programs
and provides oversight over all HRSA
activities to ensure that HRSA’s
resources are being properly used and
protected. Provides leadership,
direction, and coordination to all phases
of grants policy, administration, and
independent review of competitive
grant applications. Specifically: (1)
Serves as the Administrator’s principal
source for grants policy and financial
integrity of HRSA programs; (2)
exercises oversight over the Agency’s
business processes related to assistance
programs; (3) facilitates, plans, directs,
and coordinates the administration of
HRSA grant policies and operations; (4)
directs and carries out the independent
review of grant applications for all of
HRSA’s programs; (5) exercises the sole
responsibility within HRSA for all
aspects of grant and cooperative
agreement receipt, award, and postaward processes: and (6) provides
oversight of the management and
maintenance of, and enhancements to,
the electronic grant management system
that enables staff to perform their dayto-day work.
Division of Grants Management
Operations (RJ3)
(1) Plans, directs and carries out the
grants officer functions for all of HRSA’s
grant programs as well as awarding
official functions for various
scholarship, loan, and loan repayment
assistance programs; (2) participates in
the planning, development, and
implementation of policies and
procedures for grants and cooperative
agreements; (3) provides assistance and
technical consultation to program
offices and grantees in the application of
laws, regulations, policies, and
guidelines relative to the Agency’s grant
and cooperative agreement programs; (4)
develops standard operating procedures,
methods, and materials for the
administration of the Agency’s grants
programs; (5) establishes standards and
guides for grants management
operations; (6) reviews grantee financial
status reports and prepares reports and
E:\FR\FM\05MRN1.SGM
05MRN1
]]>Agencies
[Federal Register Volume 78, Number 43 (Tuesday, March 5, 2013)]
[Notices]
[Page 14311]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-04953]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Commission on Childhood Vaccines; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), notice is hereby given of the following
meeting:
Name: Advisory Commission on Childhood Vaccines (ACCV).
Date and Time: March 07, 2013, 10:00 a.m. to 4:00 p.m. EDT.
Place: Audio Conference Call.
The ACCV will meet on Thursday, March 7, from 10:00 a.m. to 4:00
p.m. (EDT). The public can join the meeting via audio conference call
by dialing 1-800-369-3104 on March 7 and providing the following
information:
Leader's Name: Dr. Vito Caserta.
Password: ACCV.
Agenda: The agenda items for the March meeting will include, but
are not limited to: Updates from the Division of Vaccine Injury
Compensation (DVIC), Department of Justice (DOJ), National Vaccine
Program Office (NVPO), Immunization Safety Office (Centers for Disease
Control and Prevention), National Institute of Allergy and Infectious
Diseases (National Institutes of Health) and Center for Biologics,
Evaluation and Research (Food and Drug Administration). A draft agenda
and additional meeting materials will be posted on the ACCV Web site
(https://www.hrsa.gov/vaccinecompensation/accv.htm) prior to the
meeting. Agenda items are subject to change as priorities dictate.
Public Comment: Persons interested in providing an oral
presentation should submit a written request, along with a copy of
their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau
(HSB), Health Resources and Services Administration (HRSA), Room 11C-
26, 5600 Fishers Lane, Rockville, MD 20857 or email: aherzog@hrsa.gov.
Requests should contain the name, address, telephone number, email
address, and any business or professional affiliation of the person
desiring to make an oral presentation. Groups having similar interests
are requested to combine their comments and present them through a
single representative. The allocation of time may be adjusted to
accommodate the level of expressed interest. DVIC will notify each
presenter by email, mail or telephone of their assigned presentation
time. Persons who do not file an advance request for a presentation,
but desire to make an oral statement, may announce it at the time of
the public comment period. Public participation and ability to comment
will be limited to space and time as it permits.
For Further Information Contact: Anyone requiring information
regarding the ACCV should contact Annie Herzog, DVIC, HSB, HRSA, Room
11C-26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443-
6593 or email: aherzog@hrsa.gov.
Dated: February 26, 2013.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2013-04953 Filed 3-4-13; 8:45 am]
BILLING CODE 4165-15-P
